Akzo Nobel N.V. (AKZOY)

Channel News Asia  3 hrs ago  Comment 
Hedge fund Elliott Advisors on Tuesday criticized Akzo Nobel for dismissing its request yesterday for shareholders to add items to the agenda of a Sept. 8 extraordinary general meeting.
Wall Street Journal  5 hrs ago  Comment 
The paint giant’s shares look like a one-way bet. Weak growth makes a fresh takeover bid from U.S. peer PPG ever more probable.
Financial Times  8 hrs ago  Comment 
Dutch paintmaker under pressure from hedge fund Elliott after rejecting offer from rival
Financial Times  11 hrs ago  Comment 
US hedge fund Elliott Advisors has been pushing Dutch paintmaker to talk to suitors
SeekingAlpha  10 hrs ago  Comment 
Financial Times  Jul 24  Comment 
Hedge fund wants date for shareholder vote on new chief after Büchner quits
Channel News Asia  Jul 24  Comment 
Hedge fund firm Elliott Management on Monday asked the board of Dutch paintmaker Akzo Nobel to urgently respond to its concerns about the nomination of a new chief executive.
Financial Times  Jul 19  Comment 
Ton Büchner’s departure, due to ill health, may make an eventual takeover more likely
Wall Street Journal  Jul 19  Comment 
Dutch paint giant Akzo Nobel said its chief executive has resigned for health reasons, though the unexpected move won’t slow its plan to spin off its chemicals business to appease shareholders.
SeekingAlpha  Jul 19  Comment 
Reuters  Jul 19  Comment 
The chief executive of Akzo Nobel, Ton Buechner, has stepped down for health reasons, leaving his successor to deliver the higher sales and margins promised when the Dutch paintmaker fended off a U.S. takeover attempt this year.


Related Articles


Based in the Netherlands, Akzo Nobel N.V.is a Global Fortune 500 chemicals company, producing a vast array of goods such as human and animal pharmaceuticals, paints, stains, hospital supplies, and other products. The company operates three business segments: Coatings, Chemicals, and Pharma. The Coatings segment makes decorative, industrial and protective coatings, as well as industrial finishes, car refinishes, and other industrial products. The Chemicals segment produces specialty, functional, and commodity chemicals. Its products include pulp and paper, surfactants, polymers and base chemicals, as well as high-quality salts. The Pharma segment is engaged in research, development, manufacturing, sales and services in strategic areas of human and animal healthcare. The Pharma business is named as Organon Biosciences (OBS). This segment comprises two units: Organon, which makes prescription medicines and produces complex active pharmaceutical ingredients and Intervet, which manufactures veterinary products.

Comparison to Competitors


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki